Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Kewalramani Reshma
Relationship:   Director
City:   Boston
State:   MA
   
Insider Summary:
  
   
Companies Owned :   2    
Direct Shares   276,972    

Indirect Shares

  0      
Direct Value   $44,676,283    

Indirect Value

  $0      
Total Shares   276,972      
Total Value   $44,676,283      


Vertex Pharmaceuticals Inc
 $43,218,028 Ginkgo Bioworks Holdings, Inc
 $1,458,256 Vertex Pharmaceuticals Inc
 $43,218,028 Ginkgo Bioworks Holdings, Inc
 $1,458,256
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    0    

     Stock price went up :

    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Vertex Pharmaceuticals Inc VRTX CEO & President, Direc... 2024-07-30 90,970 2018-10-08 0    Premium*  
            Ginkgo Bioworks Holdings, Inc DNA Director 2024-06-12 186,002 2022-06-10 0    Premium*  
* Premium Members only  

Records found :    25         Free Registration Required For Full Results.    Limit: 25

Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
VRTX Vertex Pharmaceuticals In... EVP and CMO   •       –      –    2018-10-08 4 AS $186.95 $430,920 D/D (2,305) 1,909 0 -
VRTX Vertex Pharmaceuticals In... EVP and CMO   •       –      –    2019-02-06 4 A $0.00 $0 D/D 13,315 15,224 0 -
VRTX Vertex Pharmaceuticals In... EVP and CMO   •       –      –    2019-02-19 4 AS $186.75 $278,163 D/D (1,488) 13,736 0 -
VRTX Vertex Pharmaceuticals In... EVP and CMO   •       –      –    2019-05-15 4 AS $165.41 $39,864 D/D (241) 13,736 0 -
VRTX Vertex Pharmaceuticals In... EVP and CMO   •       –      –    2019-10-22 4 AS $189.00 $120,582 D/D (638) 13,098 0 -
VRTX Vertex Pharmaceuticals In... EVP and CMO   •       –      –    2019-10-30 4 OE $155.57 $475,577 D/D 3,057 16,155 0 -
VRTX Vertex Pharmaceuticals In... EVP and CMO   •       –      –    2019-10-30 4 AS $199.00 $608,343 D/D (3,057) 13,098 0 -
VRTX Vertex Pharmaceuticals In... EVP and CMO   •       –      –    2019-11-08 4 AS $199.00 $101,291 D/D (509) 13,098 0 -
VRTX Vertex Pharmaceuticals In... EVP and CMO   •       –      –    2019-11-08 4 OE $155.57 $79,185 D/D 509 13,607 0 -
VRTX Vertex Pharmaceuticals In... EVP and CMO   •       –      –    2019-11-15 4 AS $205.95 $12,563 D/D (61) 13,098 0 -
VRTX Vertex Pharmaceuticals In... EVP and CMO   •       –      –    2019-11-25 4 OE $187.53 $879,891 D/D 4,692 17,790 0 -
VRTX Vertex Pharmaceuticals In... EVP and CMO   •       –      –    2019-11-25 4 AS $219.37 $1,029,284 D/D (4,692) 13,098 0 -
VRTX Vertex Pharmaceuticals In... EVP and CMO   •       –      –    2020-02-05 4 A $0.00 $0 D/D 22,187 35,285 0 -
VRTX Vertex Pharmaceuticals In... EVP and CMO   •       –      –    2020-02-06 4 OE $155.57 $372,638 D/D 2,074 37,359 0 -
VRTX Vertex Pharmaceuticals In... EVP and CMO   •       –      –    2020-02-06 4 AS $238.76 $496,600 D/D (2,074) 35,285 0 -
VRTX Vertex Pharmaceuticals In... EVP and CMO   •       •      –    2020-02-17 4 D $241.50 $227,976 D/D (944) 34,341 0 -
VRTX Vertex Pharmaceuticals In... EVP and CMO   •       •      –    2020-02-18 4 AS $241.71 $288,070 D/D (1,183) 33,158 0 -
VRTX Vertex Pharmaceuticals In... EVP and CMO   •       •      –    2020-02-24 4 D $239.23 $693,289 D/D (2,898) 30,260 0 -
VRTX Vertex Pharmaceuticals In... EVP and CMO   •       •      –    2020-02-25 4 AS $229.72 $848,371 D/D (3,634) 26,626 0 -
DNA Ginkgo Bioworks Holdings,... Director   –       •      –    2022-06-10 4 A $0.00 $0 D/D 70,921 70,921 0 -
DNA Ginkgo Bioworks Holdings,... Director   –       •      –    2022-09-30 4 OE $0.00 $0 D/D 9,818 80,739 0 -
DNA Ginkgo Bioworks Holdings,... Director   •       •      –    2024-06-12 4 OE $0.00 $0 D/D 105,263 186,002 0 -
VRTX Vertex Pharmaceuticals In... CEO & President   •       •      –    2020-05-06 4 AS $270.35 $565,882 D/D (2,074) 26,626 0 -
VRTX Vertex Pharmaceuticals In... CEO & President   •       •      –    2020-05-06 4 OE $155.57 $372,638 D/D 2,074 28,700 0 -
VRTX Vertex Pharmaceuticals In... CEO & President   •       •      –    2020-05-15 4 AS $274.37 $28,132 D/D (99) 26,626 0 -

  25  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed